Companies: 49,246 Total Market Cap: 132591774254860.43

Sartorius Stedim Biotech S.A.

EPA-DIM
Healthcare Medical Instruments & Supplies
Rank #949
Market Cap 22.01 B
Volume 11,825
Price 224.29
Change (%) 0.87%
Country or region France France

Sartorius Stedim Biotech S.A.'s latest marketcap:

22.01 B

As of 05/20/2025, Sartorius Stedim Biotech S.A.'s market capitalization has reached $22.01 B. According to our data, Sartorius Stedim Biotech S.A. is the 949th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 22.01 B
Revenue (ttm) 3.21 B
Net Income (ttm) 229.40 M
Shares Out 97.30 M
EPS (ttm) 2.37
Forward PE 43.66
Ex-Dividend Date 04/02/2025
Earnings Date 07/22/2025
Market Cap Chart
Data Updated: 05/20/2025

Sartorius Stedim Biotech S.A.'s yearly market capitalization.

Sartorius Stedim Biotech S.A. has seen its market value drop from €26.84 B to €19.61 B since 2020, representing a total decrease of 26.96% and an annual compound decline rate (CAGR) of 6.91%.
Date Market Cap Change (%)
05/20/2025 €19.61 B 5%
12/31/2024 €18.36 B -16.81%
12/29/2023 €22.07 B -20.84%
12/30/2022 €27.88 B -37.29%
12/31/2021 €44.47 B 65.66%
12/31/2020 €26.84 B

Company Profile

About Sartorius Stedim Biotech S.A.

Sartorius Stedim Biotech S.A. is a global leader in providing instruments and consumables for the biopharmaceutical industry. The company supports manufacturers and research laboratories with innovative solutions for biopharmaceutical production, analysis, and storage.

Key Products & Services

  • Cell Culture & Bioprocessing: Cell lines, culture media, bioreactors, and reagents.
  • Separation & Purification: Chromatography systems, filtration, and concentration products.
  • Storage & Transportation: Solutions for biological intermediates and finished products.
  • Fluid Management & Microbiology: Testing instruments, sterility monitoring, and pipette products.
  • Analytical Tools: Sensors, biomolecule analysis, and live cell imaging.
  • Software Solutions: Lab data management, process automation, and data analytics.
  • Water Purification & Weighing: High-purity water systems and precision weighing products.

Industries Served

The company caters to manufacturers of medications, vaccines, food, and chemicals, as well as R&D laboratories worldwide.

Corporate Overview

Founded in 1978 and headquartered in Aubagne, France, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Frequently Asked Questions

As of 05/20/2025, Sartorius Stedim Biotech S.A. (including the parent company, if applicable) has an estimated market capitalization of $22.01 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Sartorius Stedim Biotech S.A. global market capitalization ranking is approximately 949 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region France
Founded 1978
IPO Date n/a
Employees 9,901
CEO Rene Faber
Sector Healthcare
Industry Medical Instruments & Supplies
Address Zone Industrielle Les Paluds
Aubagne, 13781
France
Website https://www.sartorius.com
People Also Watch
ISRG
561.63 0.87%
EPA-EL
293.40 0.87%
BDX
176.44 0.87%
Alcon
88.80 0.87%